Geltrude Mingrone

1997–2025 年に発表

121
論文数
31,923
被引用数
74
h 指数
115
i10 指数

被引用数

Geltrude Mingrone の年別被引用数1996 年: 被引用 2 件1998 年: 被引用 3 件1999 年: 被引用 8 件2000 年: 被引用 14 件2001 年: 被引用 20 件2002 年: 被引用 32 件2003 年: 被引用 32 件2004 年: 被引用 63 件2005 年: 被引用 54 件2006 年: 被引用 66 件2007 年: 被引用 69 件2008 年: 被引用 82 件2009 年: 被引用 115 件2010 年: 被引用 100 件2011 年: 被引用 116 件2012 年: 被引用 129 件2013 年: 被引用 181 件2014 年: 被引用 143 件2015 年: 被引用 149 件2016 年: 被引用 163 件2017 年: 被引用 160 件2018 年: 被引用 159 件2019 年: 被引用 940 件2020 年: 被引用 1,746 件2021 年: 被引用 1,496 件2022 年: 被引用 1,025 件2023 年: 被引用 720 件2024 年: 被引用 1,212 件2025 年: 被引用 837 件2026 年: 被引用 36 件1997 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,693 件、この内訳の 18.5%イギリス: 引用元論文 1,274 件、この内訳の 8.8%イタリア: 引用元論文 1,030 件、この内訳の 7.1%中国: 引用元論文 922 件、この内訳の 6.4%ドイツ: 引用元論文 599 件、この内訳の 4.1%カナダ: 引用元論文 507 件、この内訳の 3.5%スペイン: 引用元論文 482 件、この内訳の 3.3%オーストラリア: 引用元論文 446 件、この内訳の 3.1%デンマーク: 引用元論文 404 件、この内訳の 2.8%フランス: 引用元論文 403 件、この内訳の 2.8%インド: 引用元論文 324 件、この内訳の 2.2%スウェーデン: 引用元論文 323 件、この内訳の 2.2%
0%18.5%その他 35.2%

分野

  • Medicine80.1%
  • Biochemistry, Genetics and Molecular Biology10.7%
  • Health Professions3.4%
  • Neuroscience1.6%
  • Psychology0.8%
  • Nursing0.8%
  • その他2.6%

トピック

  • Diabetes Treatment and Management9.8%
  • Bariatric Surgery and Outcomes7.6%
  • Diet and metabolism studies4.6%
  • Diabetes Management and Research3.9%
  • Metabolism, Diabetes, and Cancer3.3%
  • Diabetes, Cardiovascular Risks, and Lipoproteins3.2%
  • その他67.6%

共著者

全論文

検索で開く
  1. Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

    著者: , , , , , , , , , , , , , - Diabetes Care 2022 被引用: 1,950

  2. Definition and diagnostic criteria of clinical obesity

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Éric Ravussin, Edward W. Gregg, Noor B Al Busaidi, Nasreen Alfaris, Ebaa Al‐Ozairi, Lena Carlsson, Karine Clément, Jean‐Pierre Després, John B. Dixon, Gauden Galea, Lee M. Kaplan, Blandine Laferrère, Martine Laville, Soo Kun Lim, Jesús R Luna Fuentes, Vicki Mooney, Joseph Nadglowski, Urudinachi Nnenne Agbo, Magdalena Olszanecka‐Glinianowicz, An Pan, François Pattou, Philip R. Schauer, Matthias H. Tschöp, M. T. van der Merwe, Roberto Vettor, Geltrude Mingrone - The Lancet Diabetes & Endocrinology 2025 被引用: 1,324

  3. Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

    著者: , , , , , , , , , - Diabetes Care 2018 被引用: 3,513

  4. Bariatric–metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trial

    著者: , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2023 被引用: 326

  5. Joint international consensus statement for ending stigma of obesity

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Tirissa J. Reid, Ann M. Rogers, Michael Rosenbaum, Randy J. Seeley, Antonio J. Torres, John B. Dixon - Nature Medicine 2020 被引用: 1,074

  6. 2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

    著者: , , , , , , , - Diabetes Care 2019 被引用: 1,189

  7. Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial

    著者: , , , , , , , , - The Lancet 2021 被引用: 538

  8. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials

    著者: , , , , , , , - BMJ 2013 被引用: 1,338

  9. Obesity and cardiovascular disease: an ESC clinical consensus statement

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Amina Rakisheva, Xavier Rosselló, Piotr Szymański, Izabella Uchmanowicz, Christiaan Vrints, Stephan Windecker, Adam Witkowski, Katja Zeppenfeld - European Heart Journal 2024 被引用: 249

  10. Bariatric–metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial

    著者: , , , , , , , , - The Lancet 2015 被引用: 1,209

  11. Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

    著者: , , , , , , , , , - Diabetologia 2018 被引用: 1,466

  12. Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled Trial

    著者: , , , , , , , , , - Diabetes Care 2020 被引用: 181

  13. Bariatric Surgery Versus Conventional Medical Therapy for Type 2 Diabetes

    著者: , , , , , , , , , , - New England Journal of Medicine 2012 被引用: 1,783

  14. Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Desmond G. Johnston, Sangeeta R. Kashyap, Tracy Kelly, Tomasz Klupa, Judith Körner, Blandine Laferrère, Harold E. Lebovitz, Wei‐Jei Lee, Carel W. le Roux, Jeffrey I. Mechanick, Geltrude Mingrone, John M. Morton, Walter J. Pories, Robert E. Ratner, Gerry Rayman, Harvey J. Sugerman, Luc Van Gaal, Josép Vidal, Jianping Weng, Bruce M. Wolfe - Diabetes Care 2016 被引用: 971

  15. Liver biopsy-based validation, confirmation and comparison of the diagnostic performance of established and novel non-invasive steatotic liver disease indexes: Results from a large multi-center study

    著者: , , , , , , , , , , , , , , , - Metabolism 2023 被引用: 80

  16. Lancet Diabetes & Endocrinology Commission on the Definition and Diagnosis of Clinical Obesity

    著者: , , , , , , , , - The Lancet Diabetes & Endocrinology 2023 被引用: 111

  17. COVID-19 and metabolic disease: mechanisms and clinical management

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Giatgen A. Spinas, Felix Beuschlein, Rüdiger Landgraf, Francesco Rubino, Geltrude Mingrone, Stefan R. Bornstein - The Lancet Diabetes & Endocrinology 2021 被引用: 250

  18. New-Onset Diabetes in Covid-19

    著者: , , , , , , , , , , , , , , , , - New England Journal of Medicine 2020 被引用: 828

  19. Glucagon‐like peptide‐1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high‐fat diet in nonalcoholic steatohepatitis

    著者: , , , , , , , , , , , , , , , , , - Liver International 2011 被引用: 398

  20. Practical recommendations for the management of diabetes in patients with COVID-19

    著者: , , , , , , , , , , , , , , , , , , , - The Lancet Diabetes & Endocrinology 2020 被引用: 993

  21. Safety and efficacy of hydrothermal duodenal mucosal resurfacing in patients with type 2 diabetes: the randomised, double-blind, sham-controlled, multicentre REVITA-2 feasibility trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Gut 2021 被引用: 112

  22. Development and validation of an interpretable machine learning-based calculator for predicting 5-year weight trajectories after bariatric surgery: a multinational retrospective cohort SOPHIA study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Carel W. Le Roux, Robert Caiazzo, Philippe Preux, François Pattou - The Lancet Digital Health 2023 被引用: 79

  23. Comparative efficacy of different weight loss treatments on knee osteoarthritis: A network meta‐analysis

    著者: , , , , , - Obesity Reviews 2021 被引用: 78

  24. 2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

    著者: , , , , , , , - Diabetologia 2019 被引用: 498